Commentary

Nulla eu felis ligula. Nulla porttitor sapien auctor odio lobortis sagittis. Nulla facilisi. Etiam aliquet arcu ac tempor luctus. Nunc eleifend mi faucibus tellus maximus, sed auctor turpis faucibus. Orci varius natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Integer quis velit vel erat maximus feugiat nec vitae lacus. Nulla facilisi.

Sed quis vestibulum mauris. Fusce varius cursus est, ac auctor lorem rutrum sit amet. Suspendisse vel lacus eget libero auctor aliquam at nec sapien. Donec auctor, neque in tincidunt mollis, quam leo sagittis nisl, a tempor velit nunc at dui. Morbi malesuada sit amet ligula vel euismod. Cras porttitor orci non justo imperdiet vulputate. Morbi in nibh pretium, finibus augue rhoncus, pulvinar lectus. Nunc sollicitudin tempor volutpat.

25 Oct

Posted at 09:27h in Research Reports

BIVI  3.92 area It's time to get back into Biovie.  Yes, before you roll your eyes the Biotech sector is bottoming out for one.  Also, Biovie has progressed in the clinic which I've been waiting on and now have several value creation catalysts lined up for...

22 Jul

Posted at 11:17h in Research Reports

GANX- Gain Therapeutics $4 area Shares outstanding 12 million IPO 2021 at $11 per share Management owns 25%, a few other large players about 15%. Estimated real float about 2 million shares of the 12 million GAIN went public last year at 11, ran to 18 on good news and...

15 Jul

Posted at 07:40h in Portfolio Updates

Biotech has turned around after a dismal and unprecedented 16 months of valuation destruction across the board. Multiple small cap and mid cap Biotech stocks are in uptrends now.  PCSA remains on our position list and frankly still has massive upside especially if 6422 compound...

17 Jun

Posted at 11:32h in Portfolio Updates

GBOX at 1.05 This stock is dropping hard last week or so.  We do not have any news and obviously 90% of  listed stocks have had down days 5 times in the past week or so, a new market record. (90% down days usually mark short...

15 Jun

Posted at 10:22h in Portfolio Updates

A few updates on some positions and more updates this week coming. Also working to get in touch with MEEC CEO, Valour Ceo,  and WARM CEO this week. The bear market continues to roar. A few problems are obvious. Inflation at highest level since 1981.  The...

TPS
Tipping Point Stocks

Contact us at
support@TippingPointStocks.com
with any questions. We respond
within 5-15 minutes usually.

This material should not be considered investment advice. The Market Analysts Group, LLC, TippingPointStocks.com, Stockreversalspremium.com , StockReversals.com and or any of our affiliates are not a registered investment advisor. Under no circumstances should any content from this website, articles, videos, seminars or emails from TippingPointStocks.com, Stockreversals.com or Stockreversalspremium.com or any of its affiliates be used or interpreted as a recommendation to buy or sell any type of security or commodity contract. This material is not a solicitation for a trading approach to financial markets. Any investment decisions must in all cases be made by the reader or by his or her registered investment advisor. This information is for educational purposes only. All communications are subject to our Terms of Use Agreement

Disclaimer: CFTC RULE 4.41 – HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING. ALSO, SINCE THE TRADES HAVE NOT BEEN EXECUTED, THE RESULTS MAY HAVE UNDER-OR-OVER COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFIT OR LOSSES SIMILAR TO THOSE SHOWN.

All communications are subject to our terms of use agreement

indian xxnx horny desi indian cheating slime wife show boobs in webcam.